Has Suneetha Budampati, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,079 in general payments to Suneetha Budampati, MD across 304 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Suneetha Budampati, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Suneetha Budampati, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Suneetha Budampati, MD

Interventional Pain Medicine · Arlington, VANPI 1285668491

Payments from drug & device makers

$10,079in general payments, 2019–2025

Across 304 payments — averaging $33.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$2K
AbbVie$1K
Nalu Medical, Inc.$1K
Medtronic$714
Collegium Pharmaceutical, Inc.$613
Boston Scientific$446
plus $4K from 44 others

What the payments were for

Travel & lodging$1,67517%
Food & beverage$8,40483%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	50	$2,020
AbbVie(2 entities)	48	$1,262
Nalu Medical, Inc.	5	$1,177
Medtronic(2 entities)	21	$714
Collegium Pharmaceutical, Inc.	33	$613
Boston Scientific	18	$446
Vertos Medical, Inc.	6	$409
Lundbeck LLC	9	$327
MML US, Inc.	2	$266
Spinal Simplicity, LLC	3	$240
Nevro Corp.	7	$214
Ferring Pharmaceuticals Inc.	10	$203
Scilex Pharmaceuticals Inc.	9	$185
Relievant Medsystems, Inc.	2	$179
Globus Medical	2	$177
Pfizer	8	$157
Arbor Pharmaceuticals, Inc.	6	$113
Sentynl Therapeutics, Inc.	6	$106
Spine Wave, Inc.	1	$104
Novo Nordisk	1	$97
Amgen	5	$94
IBSA Pharma Inc.	5	$93
Assertio Therapeutics, Inc.	4	$75
Vertical Pharmaceuticals, LLC	4	$74
Teva Pharmaceuticals USA, Inc.	4	$71
Lilly USA, LLC	3	$65
Stryker	1	$54
Fidia Pharma USA Inc.	3	$52
Painteq LLC	2	$51
Vertex	2	$51
Biodelivery Sciences International, Inc.	3	$37
Almatica Pharma LLC	2	$36
Takeda Pharmaceuticals U.S.A., Inc.	2	$34
Pacira Therapeutics, Inc.	1	$27
Bioventus LLC	1	$24
Averitas Pharma Inc.	1	$21
Baudax Bio Inc.	1	$19
Pacira Pharmaceuticals Incorporated	1	$19
Pernix Therapeutics Holdings, Inc.	1	$17
Tersera Therapeutics LLC	1	$17
Hikma Pharmaceuticals USA	1	$17
Johnson & Johnson	1	$17
Stimwave Technologies Incorporated	1	$17
Azurity Pharmaceuticals, Inc.	1	$16
Shionogi Inc	1	$13
Forte Bio-pharma LLC	1	$12
Foundation Fusion Solutions, LLC	1	$12
Zyla Life Sciences, Inc.	1	$12
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$11
AstraZeneca	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,079 in reported general payments places this provider in the 70th percentile of 52 interventional pain medicine providers in Virginia.

See all interventional pain medicine providers in Virginia →

Medicare billing

Part B allowed, 2024

$345,467

Medicare patients

327

Services billed

3,472

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	21	$403
Gabapentin	35	$275
Oxycodone Hcl	17	$227
Tramadol Hcl	16	$118
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen	16	$108

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Arlington

Talal GhazalArlington$248K
Assaf GordonArlington$9K
Ketan PatelHaymarket$133K
Che TorryNewport News$48K
Benjamin SeemanRichmond$28K
Niteesh BhararaReston$25K
Sassan HassassianManassas$24K
Raj SurejaNewport News$23K
Alok GopalWinchester$16K
Akhtar PurvezCharlottesville$15K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →